Class information for:
Level 1: HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
287 3653 41.7 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
754 11793 MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HORMONE REPLACEMENT THERAPY Author keyword 83 17% 12% 444
2 HORMONE THERAPY Author keyword 18 11% 4% 151
3 TIMING HYPOTHESIS Author keyword 15 71% 0% 12
4 TIBOLONE Author keyword 15 18% 2% 75
5 CLIMACTERIC Journal 12 11% 3% 104
6 ESTROGEN REPLACEMENT THERAPY Author keyword 11 15% 2% 66
7 WOMENS HEALTH INITIATIVE Author keyword 8 23% 1% 32
8 CARDIOVASC EPIDEMIOL SECT Address 8 100% 0% 5
9 HRT Author keyword 8 11% 2% 65
10 PROGESTINS Author keyword 8 12% 2% 60

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HORMONE REPLACEMENT THERAPY 83 17% 12% 444 Search HORMONE+REPLACEMENT+THERAPY Search HORMONE+REPLACEMENT+THERAPY
2 HORMONE THERAPY 18 11% 4% 151 Search HORMONE+THERAPY Search HORMONE+THERAPY
3 TIMING HYPOTHESIS 15 71% 0% 12 Search TIMING+HYPOTHESIS Search TIMING+HYPOTHESIS
4 TIBOLONE 15 18% 2% 75 Search TIBOLONE Search TIBOLONE
5 ESTROGEN REPLACEMENT THERAPY 11 15% 2% 66 Search ESTROGEN+REPLACEMENT+THERAPY Search ESTROGEN+REPLACEMENT+THERAPY
6 WOMENS HEALTH INITIATIVE 8 23% 1% 32 Search WOMENS+HEALTH+INITIATIVE Search WOMENS+HEALTH+INITIATIVE
7 HRT 8 11% 2% 65 Search HRT Search HRT
8 PROGESTINS 8 12% 2% 60 Search PROGESTINS Search PROGESTINS
9 POSTMENOPAUSAL HORMONE THERAPY 7 29% 1% 20 Search POSTMENOPAUSAL+HORMONE+THERAPY Search POSTMENOPAUSAL+HORMONE+THERAPY
10 PROGESTIN 6 10% 2% 60 Search PROGESTIN Search PROGESTIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ESTROGEN PLUS PROGESTIN 69 16% 11% 408
2 ESTROGEN REPLACEMENT 67 23% 7% 256
3 ESTROGEN PROGESTIN INTERVENTIONS PEPI 60 79% 1% 38
4 PLUS PROGESTIN 59 25% 6% 207
5 17 BETA ESTRADIOL 57 13% 11% 400
6 ATHEROSCLEROTIC CORONARY ARTERIES 55 45% 2% 90
7 TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS 54 80% 1% 33
8 ENDOTHELIUM INDEPENDENT RELAXATION 51 50% 2% 75
9 DOPPLER DERIVED PARAMETERS 46 75% 1% 33
10 CONJUGATED EQUINE ESTROGENS 44 23% 5% 165

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CLIMACTERIC 12 11% 3% 104

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The protective effects of estrogen on the cardiovascular system 1999 1668 124 69%
Molecular and cellular basis of cardiovascular gender differences 2005 482 58 33%
Hormone replacement therapy and the association with coronary heart disease and overall mortality: Clinical application of the timing hypothesis 2014 10 47 83%
Menopausal Hormone Therapy and Cardiovascular Disease Risk: Utility of Biomarkers and Clinical Factors for Risk Stratification 2014 9 47 87%
Gender, sex hormones, and vascular tone 2004 264 138 63%
Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women 2006 139 149 56%
The Women's Health Initiative trial and related studies: 10 years later: A clinician's view 2014 11 44 50%
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendations 2012 55 54 39%
Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes 2011 37 75 80%
Vascular actions of estrogens: Functional implications 2008 159 391 35%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARDIOVASC EPIDEMIOL SECT 8 100% 0.1% 5
2 PROJECT AGING WOMEN 8 50% 0.3% 11
3 PROJECT AGEING WOMEN 7 53% 0.3% 10
4 COMPARAT MED CLIN 6 26% 0.5% 19
5 CATEDRA BIOQUIM CLIN 2 5 63% 0.1% 5
6 CATEDRA ANAL CLIN 2 5 44% 0.2% 8
7 MENOPAUSE CLIN 5 23% 0.5% 17
8 MED T 4 31% 0.3% 12
9 TIMSIT REPROD ENDOCRINOL 4 75% 0.1% 3
10 WOMENS HLTH INITIAT BRANCH 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000182086 WOMENS HEALTH INITIATIVE//INTERDISCIPLINARY GRP OSTEOPOROSIS//WHI STUDY
2 0.0000174233 ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7
3 0.0000171016 SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3
4 0.0000148753 TIBOLONE//TIBOLONE METABOLITES//LIVIAL
5 0.0000133247 OVARIAN SEX HORMONES//PARTNERSHIP WOMENS HLTH//NOLL 106
6 0.0000123135 SPONTANEOUS PROTEINURIA//STUDY SEX DIFFERENCES HLTH AGING DIS//SEX GENDER DIFFERENCES HLTH DIS
7 0.0000111455 ESTROGEN RECEPTOR ALPHA GENE ESR1//ESTROGEN RECEPTOR POLYMORPHISMS//ESTROGEN RECEPTOR 1
8 0.0000111005 RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE
9 0.0000091939 DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST
10 0.0000077207 COMPREHENS OBES//CELLULAR MOL SPORTS MED//ARKO MOUSE